Viewing Study NCT06745492


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-01-25 @ 8:25 PM
Study NCT ID: NCT06745492
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2024-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Sponsor: Seoul National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recovery Time View
Keywords: